The use of serosurveys following emergency vaccination, to recover the status of "foot-and-mouth disease free where vaccination is not practised"

Vaccine

Volumn 32, Issue 52, 2014, Pages 7050-7056

  Paton, D J ^a   Fussel A E ^b   Vosloo, W ^c   Dekker, A ^d   De Clercq, K ^e  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b DG SANCO G2   (Belgium)

^c CSIRO   (Australia)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

Author keywords

DIVA; Foot and mouth disease; Freedom from infection; NSP serology

Indexed keywords

ANTIBODY; FOOT AND MOUTH DISEASE VACCINE; STRUCTURAL PROTEIN; VIRUS ANTIBODY; VIRUS VACCINE;

DISEASE SURVEILLANCE; EMERGENCY TREATMENT; FEASIBILITY STUDY; FOOT AND MOUTH DISEASE; HUMAN; LAW; LIVESTOCK; NONHUMAN; REVIEW; SEROPREVALENCE; VACCINATION; VIRUS TRANSMISSION; ANIMAL; BLOOD; BOVINE; CATTLE DISEASES; EPIDEMIOLOGY; FOOT AND MOUTH DISEASE VIRUS; FOOT-AND-MOUTH DISEASE; IMMUNOLOGY; PROCEDURES; SEROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; EPIDEMIOLOGIC METHODS; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; SEROLOGIC TESTS; VACCINATION; VIRAL VACCINES;

EID: 84915758744     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.10.064     Document Type: Review

References (62)

1. van Bekkum J.G. Observation on the carrier state of cattle exposed to FMDV. Tijdschr Diergeneeskd 1959, 84:1159-1164.
2. Salt J.S. The carrier state in foot and mouth disease-an immunological view. Br Vet J 1993, 1993(149):207-223.
3. Moonen P., Jacobs L., Crienen A., Dekker A. Detection of carriers of foot-and-mouth disease virus among vaccinated cattle. Vet Microbiol 2004, 103(3-4):151-160.
4. Parida S., Cox S.J., Reid S.M., Hamblin P., Barnett P.V., Inoue T., et al. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease. Vaccine 2005, 23(44):5186-5195.
5. Tenzin Dekker A., Vernooij H., Bouma A., Stegeman A. Rate of foot-and-mouth disease virus transmission by carriers quantified from experimental data. Risk Anal 2008, 28:303-309.
6. Lombard M., Pastoret P.P., Moulin A.M. A brief history of vaccines and vaccination. Rev Sci Tech Off Int Epizoot 2007, 26:29-48.
7. Naranjo J., Cosivi O. Elimination of foot-and-mouth disease in South America: lessons and challenges. Philos Trans R Soc London Ser B: Biol Sci 2013, 368(1623):20120381. 10.1098/rstb.2012.0381.
8. Leforban Y., Gerbier G. Review of the status of foot and mouth disease and approach to control/eradication in Europe and Central Asia. Rev Sci Techn Off Int Epizoot 2002, 21:477-492.
9. Anonymous Council Directive 2003/85/EC on Community measures for the control of foot-and-mouth disease repealing Directive 85/511/EEC and Decisions 89/531/EEC and 96/665/EEC and amending Directive 92/46/EEC. Off J Eur Union 2003, 46(November):L306/1-87.
10. Muroga N., Hayama Y., Yamamoto T., Kurogi A., Tsuda T., Tsutsui T. The 2010 foot-and-mouth disease epidemic in Japan?. J Vet Med Sci 2012, 74(4):399-404.
11. Park J.H., Lee K.N., Ko Y.J., Kim S.M., Lee H.S., Shin Y.K., et al. Control of foot-and-mouth disease during 2010-2011 epidemic, South Korea. Emerg Infect Dis 2013, 19(4):655-659.
12. Geale D.W., Barnett P.V., Clarke G., Davis J., Kasari T.R. A review of OIE country status recovery using vaccinate-to-live versus vaccinate-to-die foot-and-mouth disease response policies II: waiting periods after emergency vaccination in FMD free countries. Transbound Emerg Dis 2013, 10.1111/tbed.12165.
13. Barnett P.V., Geale D.W., Clarke G., Davis J., Kasari T.R. A review of OIE country status recovery using vaccinate-to-live versus vaccinate-to-die foot-and-mouth disease response policies I: benefits of higher potency vaccines and associated DIVA test systems in post-outbreak surveillance. Transbound Emerg Dis 2013, 10.1111/tbed.12166.
14. Thrusfield M., Mansley L., Dunlop P., Pawson A., Taylor J. The foot-and-mouth disease epidemic in Dumfries and Galloway, 2001. 2: serosurveillance, and efficiency and effectiveness of control procedures after the national ban on animal movements. Vet Rec 2005, 156(9):269-278.
15. Tildesley M.J., Savill N.J., Shaw D.J., Deardon R., Brooks S.P., Woolhouse M.E., et al. Optimal reactive vaccination strategies for a foot-and-mouth outbreak in the UK. Nature 2006, 440(7080):83-86.
16. Backer J.A., Hagenaars T.J., Nodelijk G., van Roermund H.J. Vaccination against foot-and-mouth disease I: epidemiological consequences. Prev Vet Med 2012, 107(1-2):27-40.
17. Dürr S., Fasel-Clemenz C., Thür B., Schwermer H., Doherr M.G., Dohna H.Z., et al. Evaluation of the benefit of emergency vaccination in a foot-and-mouth disease free country with low livestock density. Prev Vet Med 2014, 113(1):34-46. (Epub 2013 Oct 24). 10.1016/j.prevetmed.2013.10.015.
18. Porphyre T., Auty H.K., Tildesley M.J., Gunn G.J., Woolhouse M.E. Vaccination against foot-and-mouth disease: do initial conditions affect its benefit?. PLoS One 2013, 8(10):e77616. (eCollection 2013. PMID: 24204895). 10.1371/journal.pone.0077616.
19. OIE (Office International des Epizooties/World Organisation for Animal Health) Foot and mouth disease. Office International des Epizooties 2013, OIE Standards Commission, Paris, France, Chapter 8.6. 22nd ed. Terrestrial Animal Health Code (Ed.).
20. Doel T.R. FMD vaccines. Virus Res 2003, 91(1):81-99.
21. Eblé P.L., de Koeijer A.A., de Jong M.C., Engel B., Dekker A. A meta-analysis quantifying transmission parameters of FMDV strain O Taiwan among non-vaccinated and vaccinated pigs. Prev Vet Med 2008, 83:98-106.
22. Orsel K., de Jong M.C.M., Bouma A., Stegeman J.A., Dekker A. The effect of vaccination on foot and mouth disease virus transmission among dairy cows. Vaccine 2007, 25:327-335.
23. Orsel K., de Jong M.C.M., Bouma A., Stegeman J.A., Dekker A. Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs. Vaccine 2007, 25:6381-6391.
24. Orsel K., Bouma A. The effect of foot-and-mouth disease (FMD) vaccination on virus transmission and the significance for the field?. Can Vet J 2009, 50(10):1059-1063.
25. Klinkenberg D., de Bree J., Laevens H., de Jong M.C. Within- and between-pen transmission of classical swine fever virus: a new method to estimate the basic reproduction ratio from transmission experiments. Epidemiol Infect 2002, 128(2):293-299.
26. Ugarte R. Strategy for the control of foot-and-mouth disease in Uruguay. Dev Biol (Basel) 2004, 119:415-421. (Review).
27. Doel T.R., Williams L., Barnett P.V. Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 1994, 12:592-600. 10.1016/0264-410X(94)90262-3.
28. Elnekave E., Li Y., Zamir L., Even-Tov B., Hamblin P., Gelman B., et al. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease. Vaccine 2013, 31(6):879-885.
29. Knight-Jones T.J., Bulut A.N., Gubbins S., Stärk K.D., Pfeiffer D.U., Sumption K.J., et al. Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey. Vaccine 2014, (S0264-410X(14)00134-0). 10.1016/j.vaccine.2014.01.071.
30. Barnett P.V., Carabin H. A review of emergency foot-and-mouth disease (FMD) vaccines?. Vaccine 2002, 20(11-12):1505-1514.
31. Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Hutchings G., et al. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Vaccine 2006, 24(16):3184-3190.
32. Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Paton D.J., et al. Protection against direct contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx. Vaccine 2005, 23:1106-1323.
33. Parida S., Fleming L., Oh Y., Mahapatra M., Hamblin P., Gloster J., et al. Reduction of foot-and-mouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge. Vaccine 2007, 25(45):7806-7817.
34. Parida S., Fleming L., Oh Y., Mahapatra M., Hamblin P., Gloster J., et al. Emergency vaccination of sheep against foot-and-mouth disease: significance and detection of subsequent sub-clinical infection. Vaccine 2008, 26(27-28):3469-3479.
35. Robiolo B., La Torre J., Maradei E., Perez Bascoechea C., Perez A., Seki C., et al. Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests. Vaccine 2010, 28:6235-6241.
36. Barnett P.V., Statham R.J., Vosloo W., Haydon D.T. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach?. Vaccine 2003, 21(23):3240-3248.
37. Mackay D.K1, Forsyth M.A., Davies P.R., Salt J.S. Antibody to the nonstructural proteins of foot-and-mouth disease virus in vaccinated animals exposed to infection. Vet Q 1998, 20(Suppl 2):S9L 11.
38. Ryan E., Gloster J., Reid S.M., Li Y., Ferris N.P., Waters R., et al. Clinical and laboratory investigations of the outbreaks of foot-and-mouth disease in southern England in 2007. Vet Rec 2008, 163(5):139-147.
39. Paton D.J., Ferris N.P., Hutchings G.H., Li Y., Swabey K., Keel P., et al. Investigations into the cause of foot-and-mouth disease virus seropositive small ruminants in Cyprus during 2007?. Transbound Emerg Dis 2009, 56(8):321-328.
40. Chen S.P., Lee M.C., Sun Y.F., Cheng I.C., Yang P.C., Lin Y.L., et al. Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge. Vaccine 2007, 25(22):4464-4469.
41. Brocchi E., Bergmann I., Dekker A., Paton D.J., Sammin D.J., Greiner M., et al. Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine 2006, 24:6966-6979.
42. Sørensen K.J., de Stricker K., Dyrting K., Grazioli S., Haas B. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody?. Arch Virol 2005, 150(4):805-814.
43. Arnold M.E., Paton D.J., Ryan E., Cox S.J., Wilesmith J.W. Modeling studies to estimate the prevalence of foot-and-mouth disease carriers after reactive vaccination. Proc Biol Sci 2008, 275(1630):107-115.
44. Schley D., Paton D.J., Cox S.J., Parida S., Gubbins S. The effect of vaccination on undetected persistence of foot-and-mouth disease virus in cattle herds and sheep flocks. Epidemiol Infect 2009, 137(10):1494-1504.
45. Backer J.A., Engel B., Dekker A., van Roermund H.J. Vaccination against foot-and-mouth disease, II: Regaining FMD-free status. Prev Vet Med 2012, 107(1-2):41-50.
46. Paton D.J., De Clercq K., Greiner M., Dekker A., Brocchi E., Bergmann I., et al. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. Vaccine 2006, 24:6503-6512.
47. Caporale V., Giovannini A., Zepeda C. Surveillance strategies for foot and mouth disease to prove absence of disease and absence of viral circulation. Rev Sci Tech 2012, 31(3):747-759.
48. Martin P.A.J., Cameron A.R., Greiner M. Demonstrating freedom from disease using multiple complex data sources 1: a new methodology based on scenario trees. Prev Vet Med 2007, 79:71-97.
49. Dekker A., Sammin D., Greiner M., Bergmann I., Paton D., Grazioli S., et al. Use of continuous results to compare ELISAs for the detection of antibodies to non-structural proteins of foot-and-mouth disease virus. Vaccine 2008, 26(22):2723-2732.
50. Kitching R.P. Foot and mouth disease diagnostics: requirements for demonstration of freedom from infection 2002, OIE General Session, http://www.oie.int/doc/ged/D32.PDF.
51. Greiner M., Dekker A. On the surveillance for animal diseases in small herds. Prev Vet Med 2005, 70:223-234.
52. Anonymous Workshop on the design and interpretation of post foot-and-mouth disease (FMD)-vaccination serosurveillance by NSP test-Part I (dense cattle-pig countries); Part II (Balkan area); Part III (Scandinavian and Baltic region) 2007, Anonymous, http://www.coda-cerva.be/index.php?option=com_content&view=article&id=521&Itemid=186&lang=en.
53. Cameron A.R., Baldock F.C. A new probability formula for surveys to substantiate freedom from disease. Prev Vet Med 1998, 34(1):1-17.
54. Paton D.J., Sammin D., Dyrting K., Chow M., Fleming L., Verin B., et al. Comparative evaluation of serological tests for the detection of foot-and-mouth disease virus infection in vaccinated pigs. Proceedings of the EuFMD Open Session 2006, 331-341. (Appendix 51) http://www.fao.org/ag/againfo/commissions/docs/research_group/paphos/App51.pdf.
55. Cannon R.M. Sense and sensitivity-designing surveys based on an imperfect test. Prev Vet Med 2001, 49:141-163.
56. OIE Manual of diagnostic tests and vaccines for terrestrial animals 2013, OIE, http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.01.05_FMD.pdf.
57. Waheed U., Gibson D., Paton D.J., Khan Q.M., Parida S. Development and evaluation of IgM ELISA for the detection of FMDV specific IgM antibodies in bovine and ovine sera. Proceedings of the EuFMD Open Session 2008, http://www.fao.org/ag/againfo/commissions/docs/research_group/erice/APPENDIX_68.pdf.
58. Alexandersen S., Zhang Z., Donaldson A.I., Garland A.J.M. The pathogenesis and diagnosis of FMD. J Comp Pathol 2003, 129:1-36.
59. Parida S., Anderson J., Cox S.J., Barnett P.V., Paton D.J. Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance. Vaccine 2006, 24(8):1107-1116.
60. Biswal J.K., Cokcaliskan C., Di Nardo A., Rai S., Ambrose H., Grainger P., et al. Comparison of tests that detect persistent FMDV infection in cattle. 2010 Open Session of the EuFMD Standing Technical Committee 2010, (Appendix 58) http://www.fao.org/fileadmin/user_upload/eufmd/docs/Vienna_2010/058_App58_Ccomparisono_of_tests_that_detect_persistent_FMDV_infection_in_cattle.pdf.
61. Sutmoller P., Casas Olascoaga R. The risks posed by the importation of animals vaccinated against foot and mouth disease and products derived from vaccinated animals: a review. Rev Sci Tech 2003, 22(3):823-835. (Off. Int. Epiz.).
62. Cottam E.M., Wadsworth J., Shaw A.E., Rowlands R.J., Goatley L., Maan S., et al. Transmission pathways of foot-and-mouth disease virus in the United Kingdom in 2007. PLoS Pathog 2008, 4(4):e100005.